[go: up one dir, main page]

NO20025931D0 - Biotinderivater - Google Patents

Biotinderivater

Info

Publication number
NO20025931D0
NO20025931D0 NO20025931A NO20025931A NO20025931D0 NO 20025931 D0 NO20025931 D0 NO 20025931D0 NO 20025931 A NO20025931 A NO 20025931A NO 20025931 A NO20025931 A NO 20025931A NO 20025931 D0 NO20025931 D0 NO 20025931D0
Authority
NO
Norway
Prior art keywords
biotin derivative
body fluids
extracorporeal
toxic material
mammalian
Prior art date
Application number
NO20025931A
Other languages
English (en)
Other versions
NO20025931L (no
Inventor
Bengt E B Sandberg
Scott D Wilbur
Rune Nilsson
Original Assignee
Mitra Medical Technology Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0002287A external-priority patent/SE0002287D0/xx
Application filed by Mitra Medical Technology Ab filed Critical Mitra Medical Technology Ab
Publication of NO20025931D0 publication Critical patent/NO20025931D0/no
Publication of NO20025931L publication Critical patent/NO20025931L/no

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/26Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 and B01D15/30 - B01D15/36, e.g. affinity, ligand exchange or chiral chromatography
    • B01D15/3804Affinity chromatography
    • B01D15/3823Affinity chromatography of other types, e.g. avidin, streptavidin or biotin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • External Artificial Organs (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO20025931A 2000-06-16 2002-12-11 Biotinderivater NO20025931L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0002287A SE0002287D0 (sv) 2000-06-16 2000-06-16 Biotinderivat
US21662500P 2000-07-07 2000-07-07
PCT/SE2001/001374 WO2001095857A2 (en) 2000-06-16 2001-06-18 Reusable extracorporeal colums loaded with ligand-dibiotin conjugates

Publications (2)

Publication Number Publication Date
NO20025931D0 true NO20025931D0 (no) 2002-12-11
NO20025931L NO20025931L (no) 2003-02-14

Family

ID=26655149

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20025931A NO20025931L (no) 2000-06-16 2002-12-11 Biotinderivater

Country Status (14)

Country Link
EP (1) EP1289563B1 (no)
JP (1) JP2004503299A (no)
CN (1) CN1457260A (no)
AT (1) ATE469661T1 (no)
AU (2) AU7476101A (no)
BR (1) BR0111726A (no)
CA (1) CA2412495C (no)
DE (1) DE60142286D1 (no)
HU (1) HUP0401953A3 (no)
IL (1) IL153449A0 (no)
MX (1) MXPA02012438A (no)
NO (1) NO20025931L (no)
PL (1) PL359328A1 (no)
WO (1) WO2001095857A2 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1813614E (pt) * 2006-01-25 2012-01-09 Sanofi Sa Agentes citotóxicos compreendendo novos derivados de tomaimicina
CA2705334C (en) * 2007-11-12 2018-04-17 Novozymes A/S Dual affinity polypeptides for purification
EP2714685B1 (en) * 2011-05-27 2016-10-19 Ambrx, Inc. Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives
CA2837586C (en) 2011-05-27 2018-12-11 Ambrx, Inc. Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives
JP6096371B2 (ja) 2014-02-18 2017-03-15 サヴィッド・セラピューティックス株式会社 ビオチン改変体、ストレプトアビジン変異体およびそれらの利用
CN106166311B (zh) * 2016-08-30 2018-07-13 张小曦 一种血浆净化系统及其应用
EP3562842A1 (en) * 2016-12-27 2019-11-06 H. Hoffnabb-La Roche Ag Novel biotin-specific monoclonal antibody and use thereof
EP3562845A2 (en) 2016-12-27 2019-11-06 H. Hoffnabb-La Roche Ag Novel biotin-specific monoclonal antibody and use thereof
WO2018151301A1 (ja) * 2017-02-17 2018-08-23 三井化学株式会社 抗体医薬の開発に資する創薬標的タンパク質の同定方法及び標的タンパク質に対する抗体の製造方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9100142L (sv) * 1991-01-17 1992-07-18 Bengt Sandberg En metod och ett system foer foerbaettrad in vivo reducering av diagnostiska och/eller terapeutiska substanser medelst extrakorporeal borttagning, och anvaendandet av naemnda substanser foer detta aendamaal
US5482698A (en) * 1993-04-22 1996-01-09 Immunomedics, Inc. Detection and therapy of lesions with biotin/avidin polymer conjugates
JP3441530B2 (ja) * 1994-10-03 2003-09-02 株式会社セルシード 温度応答型分離材料及びその製造方法
JP3300583B2 (ja) * 1995-11-10 2002-07-08 幹男 中山 抗原又は抗体の検出シート、検出キット及び検出方法
WO1997029114A1 (en) * 1996-02-08 1997-08-14 Board Of Regents Of The University Of Washington Biotin-containing compounds, biotinylation reagents and methods

Also Published As

Publication number Publication date
EP1289563B1 (en) 2010-06-02
DE60142286D1 (de) 2010-07-15
AU2001274761B2 (en) 2005-06-16
CA2412495C (en) 2011-02-01
AU7476101A (en) 2001-12-24
EP1289563A2 (en) 2003-03-12
ATE469661T1 (de) 2010-06-15
PL359328A1 (en) 2004-08-23
HUP0401953A2 (hu) 2004-12-28
JP2004503299A (ja) 2004-02-05
HUP0401953A3 (en) 2005-06-28
MXPA02012438A (es) 2004-09-06
WO2001095857A3 (en) 2002-03-28
CA2412495A1 (en) 2001-12-20
BR0111726A (pt) 2003-05-27
NO20025931L (no) 2003-02-14
CN1457260A (zh) 2003-11-19
IL153449A0 (en) 2003-07-06
WO2001095857A2 (en) 2001-12-20

Similar Documents

Publication Publication Date Title
BRPI0515758A (pt) dispositivo de ensaio de diagnóstico
BRPI0413350A (pt) dispositivo e métodos para coleta de amostra de fluido biológico e tratamento de componentes selecionados
WO2001036977A8 (en) Identification of disease markers involving mass-based-separation
ATE440629T1 (de) Kanüleneinführungssystem
AU2002359620A1 (en) Consolidated body fluid testing device and method
IS7842A (is) Meðferð á fettubrettusýki með eikósapentanósýru (EPA)
MXPA04000062A (es) Miembros de drenaje extensibles para conectar a tierra la proteccion por interferencia electromagnetica/interferencia por radiofrecuencia.
DE502006008299D1 (de) Geknickte lanzette
EP1578354A4 (en) TARGETS, METHODS AND REAGENTS FOR THE DIAGNOSIS AND TREATMENT OF SCHIZOPHRENIA
ATE466659T1 (de) Probenahmesystem mit phosphataseinhibitor
NO20025931D0 (no) Biotinderivater
SE0002287D0 (sv) Biotinderivat
WO2005040421A3 (en) Prognostic and diagnostic markers for cell proliferative disorders of the breast tissues
BR0205439A (pt) Método e aparelho para a concentração de patógenos que se desenvolvem em fluido
WO2001048476A3 (de) Gewinnung von biologischen komponenten aus körperflüssigkeiten
ATE382678T1 (de) Verfahren zur diagnose von rickettsia pulicis
WO2001063293A8 (en) Diagnosis and treatment of schizophrenia
FR2827176B1 (fr) Procede de fiabilisation de la tracabilite des prelevements sanguins lors des operations d'extraction notamment du plasma et des globules rouges
WO2003061622A3 (de) Verfahren und vorrichtumg tum einbringen von lebenden zellen in eine biologische körperflüssigkeit
SE0203731D0 (sv) Reagent
JP2000214163A5 (no)
ATE498020T1 (de) 5t4 rna in plasma und serum als marker für neoplastische erkrankungen
SE0102896D0 (sv) System and method for blood analysis
WO2000050593A8 (en) Beta-tubulin autoantibody in meniere's disease and other inner ear diseases and a diagnostic method
UA38285A (uk) Спосіб визначення мікрокількостей германію в тканинах тварин

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application